TCES2016 John Sinden: The CTX neural stem cell line, moving forward in multiple therapy indications

Session 3: Clinical and Commercial Translation

Sponsor: The Cell and Gene Therapy Catapult 

Chairs: James Phillips and Melanie Georgiou

Introductions by Dr Hadi Mirmalek-Sani, Cell and Gene Therapy Catapult

Keynote: Dr John Sinden, ReNeuron plc.

LINK to abstract